News | June 29, 2011

Pinnacle Oncology Acquires Rights to Unique Radioprotector from the University of Chicago

June 29, 2011 – The University of Chicago is allowing Pinnacle Oncology to acquire its technology and intellectual property rights for the development of a compound, amifostine, to prevent genomic instability caused by a variety of sources of ionizing radiation exposure, including common computed tomography (CT) scans.

Amifostine was initially developed by the U.S. Army to protect military personnel from the toxic effects of radiation exposure in the event of a nuclear war. Animal studies revealed that amifostine is very effective in protecting against genomic instability and associated long-term genomic damages resulting from radiation exposure, such as from CT scans and other diagnostic radiology and radiation oncology procedures that lead to DNA damages, chromosomal aberrations and gene mutations, all of which are associated with the cancer development processes.

"There are many potential uses for amifostine," said David Gardina, professor of radiation and cellular oncology at the University of Chicago and inventor of the technology behind the development of amifostine as a genomic stabilizing agent, "In addition to protecting against genomic instability, somatic mutagenesis and carcinogenesis, amifostine may also facilitate protection against germ line mutations. These exposures can come from a variety of sources, including common diagnostic procedures, such as computed tomography (CT) scans and more generalized environmental exposures, as recently evidenced by the nuclear plant accident in Japan." At present, none of these potential uses has been approved by the U.S. Food and Drug Administration (FDA).

According to Viren Grover, vice-chairman at Pinnacle Biologics, "It is clear that CT scans have revolutionized diagnostic imaging, and while they can provide great medical benefits, there is concern that diagnostic CT scans may be responsible for elevating genomic instability processes. Over 70 million CT scans were performed in the U.S. alone in 2007. A study led by National Institute of Cancer suggested that this may contribute to 29,000 new cancers each year, along with 14,500 deaths. Our proposal is to develop amifostine for the prevention of genomic instability in high-risk individuals undergoing CT diagnostic procedures."

For more information: www.pinnaclebiologics.com

Related Content

Johns Hopkins Surgeons Perform First Real-Time Image Guided Spine Surgery

Nicholas Theodore, M.D., (center) and the Excelsius robot he designed for image-guided spine surgery. Image courtesy of Johns Hopkins Medicine.

News | Procedure Navigation Systems | October 20, 2017
October 20, 2017 — Surgeons at The Johns Hopkins Hospital have for the first time used a real-time, image-guided robo
IBA Announces First Use of Gating With Active Scanning Proton Therapy in Italy
News | Proton Therapy | October 17, 2017
October 17, 2017 — The Trento Azienda Provinciale per i Servizi Sanitari (APSS) and IBA announced the successful comp
Infinitt Adds Organ Dose Data to Radiation Dose Management Solution
Technology | Radiation Dose Management | October 10, 2017
October 10, 2017 — Infinitt announced that its DoseM web-based...
Carestream Showcases Imaging and Healthcare IT Systems at RSNA 2017
News | Information Technology | October 10, 2017
October 10, 2017 — Carestream will be highlighting several of its imaging systems and healthcare...
Medis Releases QAngio CT v3.1
Technology | Computed Tomography (CT) | October 09, 2017
October 9, 2017 — Medis has released a new version of its QAngio...
Toshiba's Aquilion One Genesis CT Offers New Advances for Emergency Department Imaging
News | Computed Tomography (CT) | October 02, 2017
Healthcare providers now have access to fast and safe emergency department (ED) computed tomography (CT) imaging with...
Biomarker Blood Test Predicts Survival Following Localized Lung Cancer Treatment
News | Lung Cancer | September 29, 2017
A new study demonstrates that a blood test to detect cancer may predict treatment outcomes for patients with localized...
Toshiba Highlights Interventional Imaging at RSNA 2017
News | Interventional Radiology | September 27, 2017
Toshiba Medical announced it will highlight several of its latest vascular and interventional imaging solutions at the...
Cincinnati Children's Acquires Toshiba Aquilion One Genesis CT for Pediatric Care
News | Computed Tomography (CT) | September 26, 2017
September 26, 2017 — Patients at Cincinnati Children’s Hospital Medical Center now have access to the latest in dynam
Toshiba Medical Demonstrates Radiation Therapy Planning Enhancements for Aquilion LB CT at ASTRO
News | Computed Tomography (CT) | September 25, 2017
September 25, 2017 — Toshiba Medical will showcase new advanced technology on its Aquilion LB...
Overlay Init